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We present the clinical course, management, and ﬁnal outcome of spontaneous suprachoroidal hem-
orrhage (SSCH) in an age-related macular degeneration (AMD) patientda 64-year-old male receiving
antiplatelet therapy who developed SSCH during the Valsalva maneuver. In addition to our case study,
we discuss the results of a systemic review of the literature and reference lists of retrieved studies
published from January 2001 to December 2013. Among a total of 31 patients (32 eyes), acute secondary
glaucoma was a complication in 87.5% of the cases, and over half of the cases (20 eyes, 62.5%) received
surgery. Twenty cases (64.5%) were characterized by systemic hypertension (HTN), followed by cardio-
vascular or cerebral vascular disease in 17 cases (54.8%). The Valsalva maneuver was performed in ﬁve
cases (16.1%) prior to the episode. Twenty-three cases (74.2%) had abnormal hemostasis, including use of
anticoagulants or thrombolytic agents (18 cases), chronic renal failure (CRF, 5 cases), and blood dyscrasia
(3 cases). AMD was the most common (17 eyes of 16 patients, 53.1%) ocular disease. Visual acuity was
classiﬁed as hand motion (HM) or worse in 20 eyes (of 28 eyes, 71.4%) at initial presentation and in 24
eyes (of 30 eyes, 80%) upon ﬁnal examination. Anticoagulated patients with AMD should be informed of
the risk of intraocular hemorrhage. Medical therapy usually fails in the treatment of glaucoma. Surgical
intervention provides an option for the purpose of pain relief. Even so, the ﬁnal visual prognosis is
usually poor.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Suprachoroidal hemorrhage, which commonly occurs during
intraocular surgery, is infrequent and catastrophic.1,2 In extremely
rare circumstances, spontaneous suprachoroidal hemorrhage
(SSCH) occurs and presents with sudden-onset sight loss and acute
angle-closure glaucoma. The associated systemic factors include
old age,3e5 anticoagulant or thrombolytic therapy,6e10 systemic
hypertension (HTN),11e14 atherosclerosis,3,15 diabetes mellitus
(DM),10 blood dyscrasia,5,16,17 chronic renal disease,9,15,18 and the
Valsalva maneuver.19 The associated ocular factors are age-related
macular degeneration (AMD),6,20,21 glaucoma,20,22 and highof interest.
ology, National Cheng Kung
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iety of Taiwan. Published by Elsevimyopia.23 Here, we present an AMD patient receiving antiplatelet
therapy who developed SSCH during the Valsalva maneuver, and
we review the literature on this topic regarding the predisposing
factors, clinical course, and visual outcome, with the intent to
prevent the occurrence of SSCH and provide appropriate manage-
ment strategies.2. Case Report
A 64-year-old man was referred due to severe ocular pain and a
sudden loss of vision (no light perception) in the right eye 2 days
prior to presentation while straining in a pull-up exercise. Two
years previously, he experienced a visual disturbance. Visual acuity
was 20/32 in the right eye and 20/25 in the left eye. Extrafoveal
scarring was revealed in the right eye (Fig. 1, upper left), and no
obvious leakage was disclosed by ﬂuorescein angiography (Fig. 1,
upper right). In addition to systemic hypertension (HTN), due to a
brainstem stroke 3 years earlier the patient received clopidogreler Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Fundus photography of the right eye showing numerous small-sized and conﬂuent drusen (upper left), which were stained at the late stage without leakage using ﬂuorescein
angiography (upper right). These pictures were obtained 2 years prior to the episode. Slit-lamp examination shows forward displacement of the iris and lens with total iridocorneal
touch (lower left). B-Scan ultrasonography of the right eye reveals a dome-shaped choroidal detachment (arrow) with hypo-echogenous content (asterisk) in addition to a dense
vitreous hemorrhage (H) (lower right).
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Sanoﬁ Aventis, Bridgewater, NJ, USA) in order to prevent platelets
from clumping and forming blood clots.
Marked injected conjunctiva, microcystic edematous cornea,
and nearly 360 iridocorneal touch were present in the eye with a
mid-dilated and ﬁxed pupil (Fig. 1, lower left). The intraocular
pressure (IOP) was 59mmHg, and B-scan ultrasonography revealed
a dense vitreous hemorrhage and dome-shaped choroidal detach-
ment with relatively hypoechogenic content (Fig. 1, lower right).
The left eye had a deep and widely open anterior chamber, and 20/
32 vision could be achieved, despite the dry type of AMD (not
shown).
Clopidogrel bisulfate was withheld. Medication was prescribed,
including intravenous injection of mannitol, oral acetazolamide,
and topical instillation of carteolol, pilocarpine, and prednisolone.
Even following successful laser iridotomy (LI), the complete
collapse of the anterior chamber and the ocular pain were not
relieved. During the operation, rusty blood ﬂooded into the anterior
chamber following bridle traction on the superior rectus muscle. A
large amount of old blood was removed through a limbal pene-
trance with Simcoe aspiration and was drained using a superior-
temporal sclerotomy 3.75 mm away from the limbus until the
eyeball became soft. One week later, a B-scan showed a V-shaped
retinal detachment and residual vitreous hemorrhage. The painwas
relieved although hyphema persisted, and blood-stained cornea
was noted 2 months later. The IOP was 12 mmHg, but the eyeball
was phthisical thereafter.3. Methods
MEDLINE, PubMed, and Web of Science were searched during
October 2013 (English-language results, no date restrictions) for
combinations of the following terms: suprachoroidal, choroidal,hemorrhage, and spontaneous. Those cases related to injury or
globular perforation, such as corneal ulceration, or those associated
with ocular surgery were excluded.
4. Results
A total of 23 articles written since 2001 were reviewed andwere
meta-analyzed according to the clinical course, risk factors, diag-
nostic tools, management, and ﬁnal outcomes.5,6,8e10,16e19,21e34
4.1. Clinical presentation
Including our case, 15 men and 16 women (32 eyes) were
analyzed. One case had bilateral involvement for 1 year. The ages of
the patients ranged from 24 years to 90 years [mean ± standard
deviation (SD) 69.7 ± 17.6 years]. The IOP on initial presentation
ranged from 11mmHg to 70mmHg in 26 recorded eyes (mean ± SD
44.5 ± 15.3 mmHg), and only one of them did not experience acute
glaucoma during the episode. Three patients did not have a high
IOP on the ﬁrst visit until the SSCH progressed. Among six eyes
without IOP data, high IOP was mentioned in one case, one expe-
rienced pain, and one had a subsequent corneal perforation, which
was assumed to result from glaucoma. In total, acute glaucomawas
noted in 28 eyes (87.5%).
4.2. Diagnosis
In 15 cases (48.3%), dome-shaped hemorrhagic retinal de-
tachments were revealed with an ophthalmoscope in the absence
of dense vitreous hemorrhage and edematous cornea. B-Mode ul-
trasonography conﬁrmed SSCH in 71.9% (23/32) of the eyes. Five
patients had received head computer tomography examinations,
and one had a magnetic resonance imaging (MRI) examination. An
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with a swollen ciliary body and ciliochoroidal detachment in all
four quadrants.
4.3. Risk factors
Fig. 2 summarizes the systemic factors associated with the
development of SSCH. Hypertension was the most frequent sys-
temic disease (20 cases, 64.5%), followed by cardiovascular or ce-
rebrovascular disease (17 cases, 54.8%), DM (7 cases, 22.6%), and
atherosclerosis (6 cases, 19.4%). The Valsalva maneuver was noted
in ﬁve cases (16.1%) prior to the episode. Chronic renal failure (CRF,
5 cases), decompensated liver disease (1 case), disseminated
intravascular coagulation (1 case), and chronic myelogenous leu-
kemia (1 case) might have attributed to abnormal hemostasis (the
previous 3 cases are not shown in Fig. 2). Anticoagulants, anti-
platelet, and thrombolytic agents were used in 18 cases (58.1%;
Fig. 3), including warfarin (10 cases), aspirin (5 cases), heparin (4
cases), clopidogrel (3 cases), and a tissue plasminogen activator
(TPA, 2 cases). A combination of two anticoagulants was noted in
ﬁve cases. Fig. 4 shows the associated ocular diseases. The most
common factor was AMD (17 eyes, 53.1%), followed by glaucoma (3
eyes, 9.4%) and proliferative diabetic retinopathy (PDR, 2 eyes,
6.3%). High myopia (1 eye, 3.1%), retinal detachment (1 eye, not
shown in Fig. 4), and corneal inﬂammatory disease (1 eye, not
shown in Fig. 4) were seldom associated.
4.4. Treatment
In addition to medication and LI, 20 eyes (62.5%) received sur-
gical intervention. Blood drainage with sclerotomy or vitrectomy
was performed in 16 eyes (50.0%) on the 2nd day to over 30 days
after the episode. Three cases (9.4%) had subsequent global perfo-
rations, and two of them received evisceration. The other three eyes
underwent evisceration or enucleation due to pain or recurrent
SSCH following drainage.
4.5. Prognosis
Fair visual acuity on presentation was noted in two cases only
(20/40/20/40 and 20/80/20/16 following medical therapy). At
initial examination, visual acuity was hand motion (HM) or worseFig. 2. The common factors related to systemic associations in the 31 cases with SSCH. CAD
DM ¼ diabetes mellitus; HTN ¼ systemic hypertension; SSCH ¼ spontaneous suprachoroidin 20 of the 28 recorded eyes (71.4%), including eight eyes (28.6%)
presenting with no light perception. At the end, ﬁnal visual acuity
was HM or worse in 24 eyes (of 30 eyes, 80%), and no light
perception was found in 19 eyes (63.3%), including seven phthitic
eyes and ﬁve anophthalmic cases. Two cases (aged 27 years and 32
years, with hypertension and renal failure without AMD) experi-
enced signiﬁcant visual improvement after vitrectomy (20/
2000/20/25, and counting ﬁngers/20/40).5. Discussion
The associated factors possibly attributing to SSCH can be
divided into categories based on the mechanisms.18 First, fragile
choroidal or posterior ciliary vasculature plays a role, which occurs
in patients with atherosclerosis,15,18 hypertension,12 diabetic mel-
litus, old age,35 high myopia,23 and even in AMD cases with an
inactive lesion.12,18,20,21 Second, mechanical forces tear the fragile
vessels in the eye, resulting from ﬂuctuations in ocular pressure,
such as is exhibited in the Valsalva maneuver,19,36 and uncontrolled
hypertension.26 A surge in systemic pressure results in an increase
in episcleral vascular resistance and IOP, which is transmitted to the
vulnerable choroidal vessels.37 The last category, blood dyscrasia or
use of anticoagulants and antiplatelet agents, impairs hemostasis
and precipitates minor bleeding to massive hemorrhaging, which
erupts through all layers of the retina and ﬂows into the vitreous. In
our review, iatrogenic intervention of hemostasis was found in 18
cases, although a normal international normalized ratio was pre-
sent in some patients. In a literature review of 83 patients with
AMD,massive subretinal or vitreous hemorrhage occurred in 19% of
the patients taking warfarin or aspirin.12 Since the mechanism of
SSCH is multifactorial, those who have multiple risk factors may be
more vulnerable.18,28 Our case had inactive AMD, the Valsalva
maneuver, hypertension, and the patient was receiving an anti-
platelet agent. However, one casewith prostate carcinoma had only
the Valsalva maneuver,19 and another patient aged 46 years had a
hypertensive crisis only.26 It is difﬁcult to score the importance or
associated signiﬁcance of these risk factors.
Advanced age over 60 years is a well-known predisposing factor
for suprachoroidal hemorrhage.3e5 Not surprisingly, most (14/16
cases) of the patients with AMD were older than this. In the case of
patients aged over 60 years (24 eyes of 23 cases), the most common
risk factor has been shown to be abnormal coagulopathy (19/23,¼ carotid arterial disease; CRF ¼ chronic renal failure; CVA ¼ cerebrovascular accident;
al hemorrhage.
Fig. 3. The use of anticoagulants, antiplatelets, and thrombolytic agents in the cases of SSCH in the literature. The use of medication was associated with hemostasis in 18 cases.
SSCH ¼ spontaneous suprachoroidal hemorrhage; TPA ¼ tissue plasminogen activator.
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diovascular or cerebrovascular diseases (15/23, 65.2%), followed by
hypertension (14/23, 60.9%). However, among eight patients
(25.8%) younger than 60 years,5,10,26,28,29,31,34 ﬁve cases (62.5%) had
hypertension and ﬁve cases (62.5%) had DM [of them, PDR and
taking anticoagulants in 2 cases (37.5%) and AMD in another 2 cases
(37.5%)].
Following the occurrence of SSCH, bullous hemorrhagic
choroidal detachment displaces the vitreous and moves the
lenseiris diaphragm forward, resulting in secondary angle closure
glaucoma,20 which was noted in most of the events (87.5%), andFig. 4. The possible risk factors for ocular associations [not including retinal detachment (1
PDR ¼ proliferative diabetic retinopathy.even subsequent global rupture was noted.5,22,31 In the absence of
hyphema, such glaucoma may be diagnosed as a pupillary block
and be mistreated with pilocarpine, as in our case. Due to a mass
effect, SSCH-associated glaucoma is rarely responsive tomedication
and peripheral iridotomy.34,38 The diagnosis should be revised, and
B-scan ultrasonography is necessary if treatment is still in vain and
if the presence of a deep anterior chamber is noted in the fellow
eye.
Surgical drainage, including anterior chamber lavage, scle-
rotomy, and vitrectomy, is indicated for lensecornea touch, wors-
ening corneal edema, progressive angle-closure glaucoma, cataractcase) and corneal inﬂammation (1 case)]. dAMD ¼ age-related macular degeneration;
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time for surgery is controversial. In reviewing 12 recorded data for
16 eyes receiving surgical drainage, four patients underwent op-
erations within 1 week (including our case), and two of them had
recurrent SSCH.18,29 Considering the risk of rebleeding and an
incomplete lytic clot, the recommended time for drainage is at least
7e25 days following the episode.15,39,40 However, a 1-week lag did
not prevent the risk of rebleeding.6,18,29 Two eyes rebled post-
operatively although surgical drainage was performed on the 10th
day and 3 months after the episode, separately. For the remaining
cases who received surgical drainage at least 7 days or longer
(mean 17.6 days) after the episode, only two patients exhibited
visual improvement.28,29 It seems that surgical drainage is effective
for IOP control but fails to preserve vision.18 For intractable pain or
global perforation, evisceration or enucleation might be performed
(5 eyes, 15.6%).6,16,22,30,31 Other surgical interventions for pain relief
include retrobulbar alcohol injection or cyclocryotherapy.30
Except for a limited lesion at the very beginning, the fundus
picture is usually veiled by corneal edema and dense vitreous
hemorrhage. Compared with computer tomography and MRI, a B-
mode ultrasonography examination is a more available method to
conﬁrm SSCH, to exclude pathological mass lesions in the posterior
segment, such as choroidal melanoma,15 and especially for serial
observation. When a blood clot liqueﬁes completely, ultrasonog-
raphy shows homogenous and low-reﬂectivemobile opacities.15 If a
choroidal melanoma is highly suspected, surgical drainage is
inadvisable, considering tumor extension, and therefore, enucle-
ation is the most appropriate therapeutic option.10
Characteristically, visual loss occurs suddenly, and may deteri-
orate over days to weeks, especially for the delayed type or in the
case of a recurrence of SSCH. Even though the eyeball is preserved
after the SSCH is resolved, the visual outcome is generally poor,
because of the disruption of the intraocular structure and subse-
quent optic nerve baro-trauma resulting in elevation of IOP. Only
four eyes had a ﬁnal visual acuity measurement of 20/40 or bet-
ter.19,23,28,29 Localized SSCH without macular involvement was
assumed to be the reason.
Except for an 84-year-old AMD case with bilateral SSCH, the
fellow eyes of three patients (2 cases of AMD and 124-year-old case
of PDR) had a macular hemorrhage or localized subretinal or
choroidal hemorrhage.18,19,24,25 Of these, two AMD patients
received both antiplatelet and anticoagulant agents. Since SSCH is
extremely rare, AMD is not a contraindication for systemic anti-
coagulants or antiplatelet agents. However, it is important to warn
AMD patients about the predisposing risk of SSCH, to check the
prescription of anticoagulant/platelet agents, and to frequently
follow up the posterior segment after the occurrence of an intra-
ocular hemorrhage in one eye.
The limitations of our review include its retrospective nature,
the lack of a control group, and the limited number of cases. The
deﬁnite relative risk of each factor therefore cannot be clariﬁed
clearly.
The literature review presented in this work indicates that SSCH
is highly associated with hypertension, systemic anticoagulation,
and AMD. If the medication cannot be withheld, general practi-
tioners or cardiologists should consult an ophthalmologist for a
complete ophthalmic examination prior to treatment, and they
should also inform their patients of the possible risk factors asso-
ciated with SSCH. In the case of patients with intractable pain,
surgery should be performed.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.tjo.2014.10.008.References
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